Regulatory T cells are not a strong predictor of survival for patients with glioblastoma
Regulatory T cells are not a strong predictor of survival for patients with glioblastoma
Regulatory T cells (Tregs) are potentially prognostic indicators in patients with glioblastoma. If differences in frequency of Tregs in tumor or blood account for substantial variation in patient survival, then reliably measuring Tregs may enhance treatment selection and improve outcomes. We measured Tregs and CD3+ T cells in tumors and …